• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Black Diamond Therapeutics

Glowing puzzle piece fitting into puzzle
Biotech

Servier pays $70M for Black Diamond's deprioritized cancer drug

After cutting support for BDTX-4933, the biotech has licensed the RAF inhibitor to Servier for $70 million upfront and $710 million in milestones.
Nick Paul Taylor Mar 19, 2025 7:53am
hawaii parasail ocean

Lilly goes all-in on AI with new exec position—Chutes & Ladders

Oct 11, 2024 8:30am
Playing cards shuffle pack

Black Diamond reshuffles execs, drops phase 1 lung cancer drug

Oct 8, 2024 5:36am
predictive analytics

Black Diamond, Ideaya mull registrational trials for cancer meds

Sep 23, 2024 12:18pm
parachute portugal Albufeira

Amgen poaches Moderna CMO—Chutes & Ladders

Jun 16, 2023 9:30am
image of a few paragliders

Former AbbVie R&D chief tapped to run Tessera—Chutes & Ladders

Jun 3, 2022 9:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings